Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | IM |
Priorix vaccine (GSK) may have been administered intramuscularly, rather than subQ, to unknown number of patients at unknown dates in 2026 (State withheld) No side effects were reported. No additional information is available. No follow-up notes available.